StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BTIG Hims and Hers (HIMS): 'MAHA is being Implemented through HIMS with Proactive Health'
November 4, 2025 4:35 AM
BTIG analyst David Larsen reiterated a Buy rating and $85.00 price target on Hims and Hers (NYSE: HIMS).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Hims and Hers (HIMS) PT Lowered to $48 at Jefferies, 'want to see proof points of consumer traction'
November 4, 2025 8:06 AM
Needham on Hims and Hers (HIMS): 'we believe this incremental near-term investment and likely growing pains'
November 4, 2025 5:13 AM
Canaccord Genuity Reiterates Buy Rating on Hims and Hers (HIMS)
November 4, 2025 3:20 AM
After-hours movers: Palantir, Hims & Hers Health, Sarepta Therapeutics, Sanmina
November 3, 2025 4:41 PM
Hims and Hers tops revenue estimates as telehealth provider attracts more users
November 3, 2025 4:19 PM
Form 10-Q Hims & Hers Health, Inc. For: Sep 30
November 3, 2025 4:17 PM
Hims & Hers in talks with Novo Nordisk to offer Wegovy treatments
November 3, 2025 4:10 PM
Hims & Hers Health, Inc. (HIMS) Misses Q3 EPS by 4c, Offers Guidance
November 3, 2025 4:09 PM
Form 8-K Hims & Hers Health, Inc. For: Nov 03
November 3, 2025 4:09 PM
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
November 3, 2025 4:05 PM
Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put into quarter results
November 3, 2025 10:17 AM
.jpg)
